High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation-Reference-Cited by-同舟云学术

High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation

Published:2010-04-06 Issue:3 Volume:28 Page:682-688
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Mu Chuan-Yong,Huang Jian-An,Chen Ying,Chen Cheng,Zhang Xue-Guang

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-010-9515-2.pdf

Reference28 articles.

1. Yasumoto K, Hanagiri T, Takenoyama M. Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer. Gen Thorac Cardiovasc Surg. 2009;57:449–57.

2. Blank C, Gajewski TF, Mackensen A. Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy. Cancer Immunol Immunother. 2005;54:307–14.

3. XU X, et al. Clinicopathological significance of major histocompatibility complex class I-related chain A and B expression in thyroid cancer. Clin Endocrinol. 2006;91:2704–12.

4. Kaklamanis L, et al. Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am J Pathol. 1994;145:505–9.

5. Blank C, Brown I, Peterson AC. PD-L1/B7–H1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+T cells. Cancer Res. 2004;64:1140–5.

Cited by 505 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into the regulation of exosomal PD-L1 in cancer: From generation to clinical application;European Journal of Pharmacology;2024-09

2. PLD1 is a key player in cancer stemness and chemoresistance: Therapeutic targeting of cross-talk between the PI3K/Akt and Wnt/β-catenin pathways;Experimental & Molecular Medicine;2024-07-01

3. Advances in circulating tumor cells for early detection, prognosis and metastasis reduction in lung cancer;Frontiers in Oncology;2024-06-21

4. Inhibition of PD-L1 expression in non-small cell lung cancer may reduce vasculogenic mimicry formation by inhibiting the epithelial mesenchymal transformation process;Experimental Cell Research;2024-04

5. PD‐L1 Immune Checkpoint Targeted Photoactivable Liposomes (iTPALs) Prime the Stroma of Pancreatic Tumors and Promote Self‐Delivery;Advanced Healthcare Materials;2024-03-14